Developing measuring techniques for online monitoring of ex-vivo organ support system (EVOSS)

The ex-vivo organ support system (EVOSS) being developed by Tevosol, Inc. Organ transplantation remains the standard therapy for treatment of end-stage heart and lung failure. Tevosol Inc., a Canadian organ transport device company in the market, is developing an ex-vivo organ support system (EVOSS). The EVOSS is a system that is used to preserve donor […]

Read More